97
Participants
Start Date
January 31, 2006
Primary Completion Date
September 30, 2015
Study Completion Date
January 31, 2016
Fludarabine
Doses of 30 mg/m\^2 IV will be given for no less than 30 minutes daily for 4 days (Days -5 to -2)
Cyclophosphamide 150mg
A total dose of 150 mg/kg will be given as 50 mg/kg per day for 3 days (Days -4, -3, -2)
Cyclophosphamide 100mg
A total dose of 100 mg/kg will be given as 50 mg/kg per day for 2 days (Days -3, -2)
Cyclophosphamide 50mg
A total dose of 50 mg/kg will be given once at 50 mg/kg per day on Day -2
Memorial Sloan-Kettering Cancer Center, New York
Roswell Park Cancer Institute, Buffalo
Virginia Commonwealth University, MCV Hospital, Richmond
Duke University Medical Center, Durham
Children's Healthcare of Atlanta, Atlanta
BMT Program at Northside Hospital, Atlanta
H. Lee Moffitt Cancer Center, Tampa
Cincinnati Children's Hospital Medical Center, Cincinnati
University of Michigan, Ann Arbor
University of Minnesota, Minneapolis
Cook Children's Medical Center, Fort Worth
University of Texas, MD Anderson CRC, Houston
Texas Transplant Institute, San Antonio
Phoenix Children's Hospital, Phoenix
Children's Hospital Los Angeles, Los Angeles
Mattel Children's Hospital at UCLA, Los Angeles
City of Hope National Medical Center, Duarte
Stanford Hospital and Clinics, Stanford
Fred Hutchinson Cancer Research Center, Seattle
DFCI/Brigham & Women's Hospital, Boston
Hackensack University Medical Center, Hackensack
Oregon Health & Science University, Portland
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Blood and Marrow Transplant Clinical Trials Network
NETWORK
National Cancer Institute (NCI)
NIH
National Marrow Donor Program
OTHER
Medical College of Wisconsin
OTHER